Cargando…
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
BACKGROUND: NY-BR-1 has been described as a breast cancer associated differentiation antigen with intrinsic immunogenicity giving rise to endogenous T and B cell responses. The current study presents the first murine tumor model allowing functional investigation of NY-BR-1-specific immune responses...
Autores principales: | Das, Krishna, Eisel, David, Vormehr, Mathias, Müller-Decker, Karin, Hommertgen, Adriane, Jäger, Dirk, Zörnig, Inka, Feuerer, Markus, Kopp-Schneider, Annette, Osen, Wolfram, Eichmüller, Stefan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743128/ https://www.ncbi.nlm.nih.gov/pubmed/31519152 http://dx.doi.org/10.1186/s12885-019-6102-6 |
Ejemplares similares
-
In silico SNP analysis of the breast cancer antigen NY-BR-1
por: Kosaloglu, Zeynep, et al.
Publicado: (2016) -
HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
por: Hoffmann, Steve, et al.
Publicado: (2008) -
Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice
por: Sakurai, Yoshihiko, et al.
Publicado: (2006) -
IFN-γ production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8
por: Berg, Louise, et al.
Publicado: (2000) -
Unique Clinical and Pathological Features in HLA-DRB1*0401–restricted MBP 111–129–specific Humanized TCR Transgenic Mice
por: Quandt, Jacqueline A., et al.
Publicado: (2004)